Administration, Evaluation and Planning Core

管理、评估和规划核心

基本信息

批准号：
7742546
负责人：
Othon Iliopoulos
金额：
$ 16.98万
依托单位：
BETH ISRAEL DEACONESS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-06-01 至 2014-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7742546
关键词：
Administrator Advertising Advocacy Advocate Aftercare American Association of Cancer Research American Society of Clinical Oncology Area Basic Science Biological Response Modifier Therapy Boston Cancer Center Cancer and Leukemia Group B Center Core Grants Charge Clinical Clinical Investigator Clinical Research Clinical Trials Collaborations Communication Communications Media Communities Community Outreach Complement Critiques Decision Making Development Diagnosis Discipline Disease Drug Industry Early Diagnosis Eastern Cooperative Oncology Group Educational Activities Educational workshop Effectiveness Ensure Epidemiology Evaluation Event Feedback Fostering Foundations Funding Future Grant Guidelines Individual Industry Institution Intellectual Property International Investigation Israel K-Series Research Career Programs Laboratories Leadership Licensing Link Lobbying Los Angeles Malignant Neoplasms Medical center Mentors Minority Mission Monitor New England Newsletter Nodal Patient advocacy Patients Pilot Projects Process Program Description Progress Reports Property Rights Publications Recruitment Activity Renal carcinoma Report (account)Reporting Reproduction spores Research Research Activity Research Personnel Research Project Grants Resources Risk Factors SECTM1 gene San Francisco Schedule Scientist Secure Series Societies Structure Survivors System Technology Technology Transfer Translating Translational Research United States United States National Institutes of Health Update Wood material Work abstracting anticancer research base bench to bedside career career development clinical application clinical care cost cytokine follow-up interest medical schools meetings member programs response symposium treatment program web site working group

项目摘要

The purpose of the Administration, Evaluation and Planning Core is to assure the coordination of the Dana Farber/Harvard Cancer Center (DF/HCC) Kidney Cancer SPORE components and to provide oversight and leadership of the scientific, administrative and fiscal aspects of the SPORE. The SPORE will take advantage of the Beth Israel Deaconess Medical Center's large and efficient administrative staff and its central Research Administration office. It will also work closely with the administrative office of the DF/HCC and integrate its administrative activities with that of the Cancer Center. Within the DF/HCC Kidney Cancer SPORE there are several layers of oversight and evaluation. Dr. Atkins, as SPORE Director, leads the Governance Committee and oversees all aspects of the SPORE. The Governance Committee, made up of senior members of the DF/HCC Kidney Cancer Program and patient advocates meets monthly to monitor the progress of Projects, Cores and Career Development and Developmental Research Programs and facilitate prompt decision-making. SPORE Co-PIs, Drs. Iliopoulos and Kaelin share responsibility with Dr. Atkins for coordinating the Developmental Project and Career Development Award activities, respectively, with Dr. Iliopoulos also serving as Co-leader of the DF/HCC Kidney Cancer Program. The SPORE has a strong Internal Advisory Board comprised of prominent members ofthe Harvard Medical School community and representing the participating institutions and major cancer research disciplines. An External Advisory Board has been in place for the past several years and will meet as a group in New England area during years two and four of the five-year funding cycle and as individuals at DF/HCC institutions during the other years. The responsibilities of this core are to: 1) Monitor research progress and plan for the future; 2) Foster collaborative research within the SPORE and between SPOREs and other kidney cancer programs; 3) Integrate the SPORE into the DF/HCC structure; 4) Provide necessary resources and fiscal oversight; 5) Promote rapid dissemination of significant research findings; 6) Promote participation of minorities in kidney cancer research and treatment programs; 7) Encourage new investigator participation in kidney cancer research.

政府，评估和计划核心的目的是确保达纳的协调 Farber/Harvard Cancer Center（DF/HCC）肾癌孢子成分，并提供监督和孢子的科学，行政和财政方面的领导。孢子将利用贝丝以色列执事医疗中心的庞大而高效的行政人员及其中央研究管理局。它还将与DF/HCC的行政办公室紧密合作，将其行政活动与癌症中心的行政活动相结合。在DF/HCC肾癌中孢子有几层监督和评估。阿特金斯博士（Atkins）作为孢子主管，领导治理委员会并监督孢子的各个方面。治理委员会，由 DF/HCC肾脏癌症计划和患者倡导者的高级成员每月开会以监视项目，核心和职业发展和发展研究计划的进步以及促进迅速决策。孢子co-pis，博士。 Iliopoulos和Kaelin与Dr. 阿特金斯分别协调发展项目和职业发展奖活动 Iliopoulos博士还担任DF/HCC肾癌计划的共同领导者。孢子有一个强大的内部咨询委员会由哈佛医学院社区的著名成员组成并代表参与的机构和主要的癌症研究学科。外部咨询董事会在过去的几年中一直存在，并将在新英格兰地区集体见面。五年和四年级的五年筹资周期，作为DF/HCC机构的个人年。该核心的责任是：1）监控研究进度和未来计划； 2）寄养孢子内以及孢子和其他肾癌计划之间的合作研究； 3）将孢子整合到DF/HCC结构中； 4）提供必要的资源和财政监督； 5）促进重大研究结果的快速传播； 6）促进少数民族参与肾脏癌症研究和治疗计划； 7）鼓励新的研究者参加肾癌研究。